These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 28084648

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
    Bowden SA, Foster BL.
    Adv Exp Med Biol; 2019; 1148():279-322. PubMed ID: 31482504
    [Abstract] [Full Text] [Related]

  • 31. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
    Scott LJ.
    BioDrugs; 2016 Feb; 30(1):41-8. PubMed ID: 26832358
    [Abstract] [Full Text] [Related]

  • 32. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth.
    Okazaki Y, Kitajima H, Mochizuki N, Kitaoka T, Michigami T, Ozono K.
    Eur J Pediatr; 2016 Mar; 175(3):433-7. PubMed ID: 26459154
    [Abstract] [Full Text] [Related]

  • 33. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia.
    Hofmann C, Seefried L, Jakob F.
    Drugs Today (Barc); 2016 May; 52(5):271-85. PubMed ID: 27376160
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hypophosphatasia: Natural history study of 101 affected children investigated at one research center.
    Whyte MP, Wenkert D, Zhang F.
    Bone; 2016 Dec; 93():125-138. PubMed ID: 27576207
    [Abstract] [Full Text] [Related]

  • 38. Hypophosphatasia: A Unique Disorder of Bone Mineralization.
    Villa-Suárez JM, García-Fontana C, Andújar-Vera F, González-Salvatierra S, de Haro-Muñoz T, Contreras-Bolívar V, García-Fontana B, Muñoz-Torres M.
    Int J Mol Sci; 2021 Apr 21; 22(9):. PubMed ID: 33919113
    [Abstract] [Full Text] [Related]

  • 39. Hypophosphatasia.
    Linglart A, Biosse-Duplan M.
    Curr Osteoporos Rep; 2016 Jun 21; 14(3):95-105. PubMed ID: 27084188
    [Abstract] [Full Text] [Related]

  • 40. Enzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis: a case series.
    Kosnik-Infinger L, Gendron C, Gordon CB, Pan BS, van Aalst JA, Vogel TW.
    Neurosurg Focus; 2015 May 21; 38(5):E10. PubMed ID: 25929963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.